Cite
HARVARD Citation
Verstockt, B. et al. (n.d.). A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases. Expert opinion on drug safety. 16 (7), pp. 809-821. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Verstockt, B. et al. (n.d.). A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases. Expert opinion on drug safety. 16 (7), pp. 809-821. [Online].